img

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Prostate Cancer Diagnosis and Therapy market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prostate Cancer Diagnosis and Therapy market research.
Key companies engaged in the Prostate Cancer Diagnosis and Therapy industry include AbbVie, Astellas Pharma, AstraZeneca, Bayer, Dendreon Pharmaceuticals, Ferring, Ipsen Pharma, Johnson and Johnson and Sanofi, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Prostate Cancer Diagnosis and Therapy were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Prostate Cancer Diagnosis and Therapy market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prostate Cancer Diagnosis and Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie
Astellas Pharma
AstraZeneca
Bayer
Dendreon Pharmaceuticals
Ferring
Ipsen Pharma
Johnson and Johnson
Sanofi
Tolmar Pharmaceuticals
Segment by Type
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy

Segment by Application


General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prostate Cancer Diagnosis and Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Therapy Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Therapy Market Perspective (2018-2034)
2.2 Prostate Cancer Diagnosis and Therapy Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnosis and Therapy Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Prostate Cancer Diagnosis and Therapy Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Region (2024-2034)
2.3 Prostate Cancer Diagnosis and Therapy Market Dynamics
2.3.1 Prostate Cancer Diagnosis and Therapy Industry Trends
2.3.2 Prostate Cancer Diagnosis and Therapy Market Drivers
2.3.3 Prostate Cancer Diagnosis and Therapy Market Challenges
2.3.4 Prostate Cancer Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnosis and Therapy Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Therapy Revenue
3.4 Global Prostate Cancer Diagnosis and Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Therapy Revenue in 2024
3.5 Prostate Cancer Diagnosis and Therapy Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnosis and Therapy Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnosis and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Therapy Breakdown Data by Type
4.1 Global Prostate Cancer Diagnosis and Therapy Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Type (2024-2034)
5 Prostate Cancer Diagnosis and Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Diagnosis and Therapy Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Prostate Cancer Diagnosis and Therapy Market Size (2018-2034)
6.2 North America Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Therapy Market Size (2018-2034)
7.2 Europe Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size (2018-2034)
8.2 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnosis and Therapy Market Size (2018-2034)
9.2 Latin America Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size (2018-2034)
10.2 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Prostate Cancer Diagnosis and Therapy Introduction
11.1.4 AbbVie Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Prostate Cancer Diagnosis and Therapy Introduction
11.2.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Prostate Cancer Diagnosis and Therapy Introduction
11.3.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Prostate Cancer Diagnosis and Therapy Introduction
11.4.4 Bayer Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Dendreon Pharmaceuticals
11.5.1 Dendreon Pharmaceuticals Company Detail
11.5.2 Dendreon Pharmaceuticals Business Overview
11.5.3 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Introduction
11.5.4 Dendreon Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.5.5 Dendreon Pharmaceuticals Recent Development
11.6 Ferring
11.6.1 Ferring Company Detail
11.6.2 Ferring Business Overview
11.6.3 Ferring Prostate Cancer Diagnosis and Therapy Introduction
11.6.4 Ferring Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.6.5 Ferring Recent Development
11.7 Ipsen Pharma
11.7.1 Ipsen Pharma Company Detail
11.7.2 Ipsen Pharma Business Overview
11.7.3 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Introduction
11.7.4 Ipsen Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.7.5 Ipsen Pharma Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Introduction
11.8.4 Johnson and Johnson Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.8.5 Johnson and Johnson Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Prostate Cancer Diagnosis and Therapy Introduction
11.9.4 Sanofi Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Tolmar Pharmaceuticals
11.10.1 Tolmar Pharmaceuticals Company Detail
11.10.2 Tolmar Pharmaceuticals Business Overview
11.10.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Introduction
11.10.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.10.5 Tolmar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Hormone Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Biologic Therapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Prostate Cancer Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Prostate Cancer Diagnosis and Therapy Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Prostate Cancer Diagnosis and Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prostate Cancer Diagnosis and Therapy Market Share by Region (2018-2023)
Table 10. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Prostate Cancer Diagnosis and Therapy Market Share by Region (2024-2034)
Table 12. Prostate Cancer Diagnosis and Therapy Market Trends
Table 13. Prostate Cancer Diagnosis and Therapy Market Drivers
Table 14. Prostate Cancer Diagnosis and Therapy Market Challenges
Table 15. Prostate Cancer Diagnosis and Therapy Market Restraints
Table 16. Global Prostate Cancer Diagnosis and Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prostate Cancer Diagnosis and Therapy Market Share by Players (2018-2023)
Table 18. Global Top Prostate Cancer Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Therapy as of 2024)
Table 19. Ranking of Global Top Prostate Cancer Diagnosis and Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnosis and Therapy Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnosis and Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnosis and Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Type (2024-2034)
Table 29. Global Prostate Cancer Diagnosis and Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Application (2024-2034)
Table 33. North America Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Prostate Cancer Diagnosis and Therapy Product
Table 51. AbbVie Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Astellas Pharma Company Detail
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Prostate Cancer Diagnosis and Therapy Product
Table 56. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. AstraZeneca Company Detail
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Prostate Cancer Diagnosis and Therapy Product
Table 61. AstraZeneca Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 62. AstraZeneca Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Prostate Cancer Diagnosis and Therapy Product
Table 66. Bayer Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Dendreon Pharmaceuticals Company Detail
Table 69. Dendreon Pharmaceuticals Business Overview
Table 70. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product
Table 71. Dendreon Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 72. Dendreon Pharmaceuticals Recent Development
Table 73. Ferring Company Detail
Table 74. Ferring Business Overview
Table 75. Ferring Prostate Cancer Diagnosis and Therapy Product
Table 76. Ferring Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 77. Ferring Recent Development
Table 78. Ipsen Pharma Company Detail
Table 79. Ipsen Pharma Business Overview
Table 80. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product
Table 81. Ipsen Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 82. Ipsen Pharma Recent Development
Table 83. Johnson and Johnson Company Detail
Table 84. Johnson and Johnson Business Overview
Table 85. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product
Table 86. Johnson and Johnson Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 87. Johnson and Johnson Recent Development
Table 88. Sanofi Company Detail
Table 89. Sanofi Business Overview
Table 90. Sanofi Prostate Cancer Diagnosis and Therapy Product
Table 91. Sanofi Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Tolmar Pharmaceuticals Company Detail
Table 94. Tolmar Pharmaceuticals Business Overview
Table 95. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product
Table 96. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 97. Tolmar Pharmaceuticals Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnosis and Therapy Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnosis and Therapy Market Share by Type: 2024 VS 2034
Figure 3. Hormone Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Biologic Therapy Features
Figure 6. Targeted Therapy Features
Figure 7. Global Prostate Cancer Diagnosis and Therapy Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Prostate Cancer Diagnosis and Therapy Market Share by Application: 2024 VS 2034
Figure 9. General Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Prostate Cancer Diagnosis and Therapy Report Years Considered
Figure 12. Global Prostate Cancer Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Prostate Cancer Diagnosis and Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Prostate Cancer Diagnosis and Therapy Market Share by Region: 2024 VS 2034
Figure 15. Global Prostate Cancer Diagnosis and Therapy Market Share by Players in 2024
Figure 16. Global Top Prostate Cancer Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue in 2024
Figure 18. North America Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2034)
Figure 20. United States Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2034)
Figure 24. Germany Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Share by Region (2018-2034)
Figure 32. China Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2034)
Figure 40. Mexico Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2034)
Figure 44. Turkey Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 47. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 50. Dendreon Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 51. Ferring Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 52. Ipsen Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 53. Johnson and Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 55. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed